Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards

    DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards support researchers studying tumors in NF1 and other inherited Rasopathy syndromes to improve diagnosis and management.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    DHART SPORE DRP and CEP awards are now listed with a December 1, 2026 submission deadline. The listing includes version 3.0 guidelines for both programs.

    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

    NCI funds cancer research centers for 2027–2029 to advance prevention, detection, diagnosis, and treatment through translational research reaching a human endpoint; a clinical trial is required.

    HHS-NIH11Due Jan 25, 2027$7,600,000

    Clinical Research Award (CRA)

    Clinical Research Award (CRA) supports researchers studying treatments, interventions, and disease management for neurofibromatosis to improve health outcomes and everyday functioning.

    CTFDue Feb 1, 2027$200,000

    Drug Discovery Initiative (DDI)

    Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.

    CTFDue Feb 10, 2027$200,000

    Dermatopathology Research Career Development Award

    Dermatopathology Research Career Development Award supports junior faculty with salary support for research and education that advance dermatopathology and dermatology and build academic careers.

    Dermatology FoundationDue Jan 1, 2027$150,000Limited submission

    Pilot Awards - Neuroendocrine Tumor Research Foundation

    Pilot Awards - Neuroendocrine Tumor Research Foundation support researchers' pilot and feasibility studies of neuroendocrine cancers to advance early detection, new treatments, and personalized care.

    NETRFForecasted Mar 16, 2027$100,000Forecasted